PSCH 📈 Invesco S&P SmallCap - Overview
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138E1495 • Health
PSCH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices, Equipment
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard. ‣ Company URL: http://www.invesco.com/us ‣ Domicile: United States
Additional Sources for PSCH ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PSCH ETF Overview
Market Cap in USD | 188m |
Category | Health |
TER | 0.29% |
IPO / Inception | 2010-04-07 |
PSCH ETF Ratings
Growth 5y | 6.84% |
Fundamental | - |
Dividend | 22.7% |
Rel. Strength Industry | -87 |
Analysts | - |
Fair Price Momentum | 40.76 USD |
Fair Price DCF | - |
PSCH Dividends
Dividend Yield 12m | 0.23% |
Yield on Cost 5y | 0.24% |
Annual Growth 5y | % |
Payout Consistency | 24.4% |
PSCH Growth Ratios
Growth Correlation 3m | 47.9% |
Growth Correlation 12m | 78% |
Growth Correlation 5y | -23.5% |
CAGR 5y | 1.13% |
CAGR/Mean DD 5y | 0.05 |
Sharpe Ratio 12m | 0.16 |
Alpha | -20.83 |
Beta | 0.99 |
Volatility | 23.61% |
Current Volume | 15.5k |
Average Volume 20d | 8.1k |
What is the price of PSCH stocks?
As of December 29, 2024, the stock is trading at USD 45.13 with a total of 15,453 shares traded.
Over the past week, the price has changed by -0.05%, over one month by -6.12%, over three months by -1.06% and over the past year by +3.61%.
As of December 29, 2024, the stock is trading at USD 45.13 with a total of 15,453 shares traded.
Over the past week, the price has changed by -0.05%, over one month by -6.12%, over three months by -1.06% and over the past year by +3.61%.
Is Invesco S&P SmallCap a good stock to buy?
Neither. Based on ValueRay Analyses, Invesco S&P SmallCap is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 6.84 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PSCH as of December 2024 is 40.76. This means that PSCH is currently overvalued and has a potential downside of -9.68%.
Neither. Based on ValueRay Analyses, Invesco S&P SmallCap is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 6.84 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PSCH as of December 2024 is 40.76. This means that PSCH is currently overvalued and has a potential downside of -9.68%.
Is PSCH a buy, sell or hold?
Invesco S&P SmallCap has no consensus analysts rating.
Invesco S&P SmallCap has no consensus analysts rating.
What are the forecast for PSCH stock price target?
According to ValueRays Forecast Model, PSCH Invesco S&P SmallCap will be worth about 45.3 in December 2025. The stock is currently trading at 45.13. This means that the stock has a potential upside of +0.4%.
According to ValueRays Forecast Model, PSCH Invesco S&P SmallCap will be worth about 45.3 in December 2025. The stock is currently trading at 45.13. This means that the stock has a potential upside of +0.4%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 45.3 | 0.4% |